1 / 30

Fever in Children (Part 2)

Fever in Children (Part 2). In febrile infants 0-3 months old: Recognize the risk of occult bacteremia Investigate thoroughly In viral infections, do not prescribe antibiotics In those requiring antibiotics, prescribe according to likely causative organisms and local resistance patterns

lan
Télécharger la présentation

Fever in Children (Part 2)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Fever in Children (Part 2) • In febrile infants 0-3 months old: • Recognize the risk of occult bacteremia • Investigate thoroughly • In viral infections, do not prescribe antibiotics • In those requiring antibiotics, prescribe according to likely causative organisms and local resistance patterns • Investigate patients with FUO appropriately • In febrile patients, consider life threatening causes • Aggressively and immediately treat patients with fever from serious causes • Consider non-infectious causes of hyperthermia (eg. heat stroke, drug reactions, malignant neuroleptic syndrome)

  2. Fever in Children (Part 2) • Acute fever • Who is at risk? • For what germs? • Life threatening acute febrile illnesses • Non-infectious causes of acute fever • Chronic fever • Approach to PUO

  3. Fever in Children (Part 2) • High Risk Populations (Clinical) • Neonates • GBS, E.coli, Listeria, HSV, Enterovirus • Hyperpyrexia (temp >40 deg. Celsius) • Meningitis, bacteremia, pneumonia, heat stroke • Fever with petechiae • N. meningitidis, also H.flu, S.pneumo.

  4. Fever in Children (Part 2) • High Risk Populations (Immunocompromised) • Sickle Cell • Sepsis, pneumonia, meningitis by S.pneumo • Osteomyelitis by Salmonella and S.aureus • Asplenia • Bacteremia and meningitis • (N.meningitidis, H.flu, S.pneumo)

  5. Fever in Children (Part 2) • Immunocompromised Populations • Agammaglobulinemia • Bactermia, sinoplumonary infections • AIDS • S.pneumo, H.flu, Salmonella, others • Atypicals (PCP, cryptosporidium) • Complement deficiency • N.meningitidis

  6. Fever in Children (Part 2) • Immunocompromised Populations • Malignancy (+/- neutropenia) • Gram negative enterics, S.aureus, coag. neg. Staph, Candida & Aspergillus • Congenital heart disease • Endocarditis, brain abscess (R-to-L shunt) • CVL • S.aureus, coag negative Staph, Candida

  7. Fever in Children (Part 2) • Life threatening causes of fever • Sepsis • Meningitis • Acute rheumatic fever • Endocarditis (separate lecture) • Kawasaki disease • Others (eg. Rocky Mountain spotted fever, etc)

  8. Fever in Children (Part 2) • Acute rheumatic fever • Etiology: • Link between GAS and ARF • Peak incidence of initial attack and recurrences 5-15 • Coincides with greatest risk for GAS pharyngitis • Some serotypes more rheumatogenic than others • Epidemiology: • As high as 50 per 100,00 children in some countries • Incidence in USA • 100-200/100,000 in 1900 • As low as 0.5/100,000 in 1980 • Most common cause of acquired heart disease worldwide • Decline in industrial countries precedes antibiotic era

  9. Fever in Children (Part 2) • Acute rheumatic fever • Pathogenesis: • Cytotoxic theory • GAS produces toxins that are toxic to mammalian cardiac cells (eg. Streptolysin O) • Difficult to explain latent phase between GAS infection and onset of ARF • Immune-mediated theory • Similar to other immune mediated diseases • Several GAS products and constituents are immunogenic and cross-reactive with mammalian tissue components

  10. Fever in Children (Part 2) • Acute rheumatic fever • Clinical Manifestations: • No clinical or laboratory test • Jones criteria • 5 major and 4 minor criteria • MUST have evidence of recent GAS infection • Either 2 major criteria or 1 major and two minor for diagnosis • To diagnose initial attack not recurrences • Usually recurrences meet Jones criteria • Chorea can be only manifestation of ARF

  11. Fever in Children (Part 2) • Jones criteria • Proof of GAS infection • Positive throat culture or rapid strep test • Elevated or increasing strep antibody titres • Major criteria • Carditis • Polyarthritis • Erythema marginatum • Subcutaneous nodules • Chorea • Minor criteria • Arthrlagia • Fever • Increased ESR or CRP • Prolonged PR interval

  12. Erythemamarginatum

  13. Fever in Children (Part 2) • Kawasaki disease • Etiology remains unknown • KD-associated antigen suggests viral cause • Epidemiology • 11-39/100,000 depending on population • More common in Asian/Pacific Islander populations • 80% less than 5 years old • Pathology • Medium-sized artery vasculitis

  14. Fever in Children (Part 2) • Kawasaki disease • Clinical Manifestations • High fever • Unremitting, unresponsive to antibiotics • Generally 1-2 wk, up to 3-4 weeks (Min 4 days) • Irritable • Five principal clinical criteria (Need 4 of 5) • Conjuncitivits • Oropharyngeal erythema • Changes in extremities • Lymphadenopathy • Rash

  15. Fever in Children (Part 2) • Kawasaki disease • Principal Clinical Criteria • Conjuncitivitis • Bilateral, non-exudative with limbal sparing • Oropharyngeal erythema • Strawberry tongue, cracked, dry lips • Extremity changes • Early: Edema and erythema of hands and feet • Late: Distal (periungual) desquamation

  16. Fever in Children (Part 2) • Kawasaki disease • Principal Clinical Criteria • Lymphadenopathy • Non-suppurative cervical lymphadenopathyUsually unilateral • Greater than 1.5cm • Rash • Various forms (EM, maculopapular, scarletiniform) • Accentuation in groin area • NOT vesicular

  17. Kawasaki disease Conjunctivitis

  18. Fever in Children (Part 2) • Kawasaki disease • Associated symptoms • GI symptoms • Hydrops of gall bladder • Hepatitis • Sterile urethritis/pyuria • Arthritis • Cardiac aneurysms • 25% of untreated patients

  19. Fever in Children (Part 2) • Kawasaki disease • Treatment • Referral to centre with experience treating • Intravenous Immunoglobulin (2g/kg) • Sometimes requires second dose • Aspirin • Initially high dose (80-100mg/kg/d divided q6h) • Later antithrombotic dose (3-5mg/kg/d) • After afebrile for 48hr • Continue 6-8 weeks • Influenza vaccine (prevent Reye syndrome)

  20. Fever in Children (Part 2) • Non-infectious causes • Heat injuries (cramps, exhaustion, stroke) • Children more vulnerable than adults • Heat cramps • Mild dehydration/salt depletion • Calf/hamstring muscles • Heat syncope • Heat edema • Heat tetany • Respond to oral hydration and cool environment

  21. Fever in Children (Part 2) • Non-infectious causes • Heat exhaustion • Symptoms • Elevated core temperature • Headache, Nx, Vx, dizziness • Orthostasis/syncope, weakness, piloerection • Treatment • Move to cool environment, remove excess clothing • Active cooling (ice packs to groin/axillae) • Fluids (po if tolerated, otherwise IV) • Temperature monitoring • Transfer to emergency facility if not responding

  22. Fever in Children (Part 2) • Non-infectious causes • Heat stroke • Sports related • Profuse sweating, intense exertion • “Classic” • Dry, hot skin • Slower onset • Elderly or chronically ill persons

  23. Fever in Children (Part 2) • Non-infectious causes • Heat stroke • Core temperature >40 degrees • CNS disturbance • Potential tissue damage • Treatment • Constant monitoring of ABC/GCS • Rapid cooling via cold water immersion • Can discontinue once temp under 39 degrees • IV fluids • NS or RL: 800ml/m2 in first hour

  24. Fever in Children (Part 2) • Non-infectious causes • Drug reactions • Hypersensitivity reactions • Altered thermoregulation • Idiosyncratic reaction

  25. Fever in Children (Part 2) • Non-infectious causes • Malignant neuroleptic syndrome • Few days after starting neuroleptic agent • After withdrawl of dopaminergic agent • Mortality up to 20-30% • Symptoms: • Fever greater then 38 degrees • Encephalopathy (Delerium) • Vital signs unstable – tachycardia, diaphoresis • Elevated CPK • Rigidity of muscles (Dystonia)

  26. Fever in Children (Part 2) • Fever of Unknown origin • Definition • Fever documented by health care provider • No cause identified after 3 weeks • Or after 1 week observation in hospital • Etiology • Neoplastic • Infectious • Atypical organisms • Atypical presentation of common organism • Rheumatologic • Drug fevers

  27. Fever in Children (Part 2) • Fever of Unknown origin (History) • Age • Children: Resp&GU infection, localized infection, JIA, rarely leukemia • Adolescents: TB, IBD, autoimmune disease, lymphoma • Travel history • malaria • Zoonotic exposures • Leptospirosis, tularemia, lyme disease • Pica/atypical diet • Toxacara canis, toxoplasmosis • Genetic background • Periodic fever syndromes (FMF, PFAPA, TRAPS) • Medication history

  28. Fever in Children (Part 2) • Fever of Unknown origin (Assessment) • Pattern of fever • Eg. Quotidien with am hypothermia vs constant with variable spikes • Physical examination • Eye findings (Conjunctivitis, uveitis, chorioretinitis) • Sinus tenderness, dental problems, thyroiditis • Hepatosplenomegaly, lymphadenopathy, masses • Murmur (endocarditis) • Skin (petechiae, splinter hemorrhages, nodules, etc)

  29. Fever in Children (Part 2) • Fever of Unknown origin (Labs) • Directed by history and physical • Consider: • CBC with differential • Blood culture • Aerobic – specials (eg. leptospirosis, etc) based on clinical assessment • May need multiple cultures • Urinalysis • ESR/CRP • >30 consistent with infectious, autoimmune, malignancy • >100 consistent with TB, KD, autoimmune, malignancy • TB Skin test • Radiographs (based on clinical assessment) • Serology (CMV, EBV, Bartonella, Toxoplasma, Borrelia, Salmonella, etc) • Other tests (BMA, bone scan, Echo) as appropriate

  30. Fever in Children (Part 2) • Fever of Unknown origin • Treatment • Based on underlying diagnosis • Trial of antimicrobial generally avoided • Exception: Critically ill children • Prognosis • Based on underlying diagnosis • Generally better prognosis in children than adults • Often resolves spontaneously without diagnosis • As many as 25% of cases remain elusive

More Related